We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for UiPath (PATH) Q2 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
Analysts on Wall Street project that UiPath (PATH - Free Report) will announce quarterly earnings of $0.03 per share in its forthcoming report, representing a decline of 66.7% year over year. Revenues are projected to reach $302.92 million, increasing 5.4% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some UiPath metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Revenue- Licenses' should come in at $109.52 million. The estimate points to a change of -8.2% from the year-ago quarter.
It is projected by analysts that the 'Net New ARR' will reach $37.53 million. The estimate compares to the year-ago value of $59 million.
The average prediction of analysts places 'ARR' at $1.55 billion. The estimate is in contrast to the year-ago figure of $1.31 billion.
Over the past month, UiPath shares have recorded returns of +8.8% versus the Zacks S&P 500 composite's +2.5% change. Based on its Zacks Rank #3 (Hold), PATH will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for UiPath (PATH) Q2 Earnings, Beyond Revenue and EPS
Analysts on Wall Street project that UiPath (PATH - Free Report) will announce quarterly earnings of $0.03 per share in its forthcoming report, representing a decline of 66.7% year over year. Revenues are projected to reach $302.92 million, increasing 5.4% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some UiPath metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Revenue- Licenses' should come in at $109.52 million. The estimate points to a change of -8.2% from the year-ago quarter.
It is projected by analysts that the 'Net New ARR' will reach $37.53 million. The estimate compares to the year-ago value of $59 million.
The average prediction of analysts places 'ARR' at $1.55 billion. The estimate is in contrast to the year-ago figure of $1.31 billion.
View all Key Company Metrics for UiPath here>>>
Over the past month, UiPath shares have recorded returns of +8.8% versus the Zacks S&P 500 composite's +2.5% change. Based on its Zacks Rank #3 (Hold), PATH will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>